Co-Authors
This is a "connection" page, showing publications co-authored by Pasquale Pagliano and Alfonso Masullo.
Connection Strength
0.115
-
PD-L1 Dysregulation in COVID-19 Patients. Front Immunol. 2021; 12:695242.
Score: 0.059
-
Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study. Front Pharmacol. 2020; 11:857.
Score: 0.055
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.